Anticancer agent containing dendritic cell having RNA virus transferred thereinto

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8889118
SERIAL NO

11630532

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides anticancer agents comprising dendritic cells introduced with RNA viruses. The present invention also provides methods for producing anticancer agents, which comprise the step of preparing dendritic cells introduced with RNA viruses. The present invention also provides methods for treating cancers using dendritic cells introduced with RNA viruses. The present invention provides effective methods for treating cancers, which use RNA viruses and dendritic cells in combination.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DNAVEC RESEARCH INC25-11 KANNONDAI 1-CHOME TSUKUBA-SHI IBARAKI 305-0856 JAPAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hasegawa, Mamoru Tsukuba, JP 145 1396
Kondo, Haruhiko Fukuoka, JP 54 493
Okano, Shinji Fukuoka, JP 8 75
Shibata, Satoko Fukuoka, JP 3 43
Sueishi, Katsuo Fukuoka, JP 11 82
Yonemitsu, Yoshikazu Chiba, JP 36 159

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 18, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00